Clinical Trial Update: A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating medical cannabis aerosol inhaled via the Syqe fixed-dose inhaler as add-on treatment for diabetic peripheral neuropathic pain;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• medical cannabis aerosol inhaled via Syqe Inhaler (cannabis aerosol inhalation)

Snippet

Sponsor: Syqe Medical | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: RECRUITING